Selected article for: "case control and short term"

Author: De wals, P.; Divangahi, M.
Title: Could seasonal influenza vaccination influence COVID-19 risk?
  • Cord-id: xjklin0b
  • Document date: 2020_9_3
  • ID: xjklin0b
    Snippet: Background: With possible resurgence of the SARS-CoV-2 and low seasonal influenza virus circulation next winter, reviewing evidence on a possible interaction between influenza vaccination and COVID-19 risk is important. Objective: To review studies on the effect of influenza vaccines on non-influenza respiratory disease (NIRD). Methods: Using different search strategies, 18 relevant studies were identified and their strength, limitations and significance were assessed. Results: Analysis of 4 RCT
    Document: Background: With possible resurgence of the SARS-CoV-2 and low seasonal influenza virus circulation next winter, reviewing evidence on a possible interaction between influenza vaccination and COVID-19 risk is important. Objective: To review studies on the effect of influenza vaccines on non-influenza respiratory disease (NIRD). Methods: Using different search strategies, 18 relevant studies were identified and their strength, limitations and significance were assessed. Results: Analysis of 4 RCT datasets did not suggest increased NIRD risk in recipients of live-attenuated vaccines (LAIV) and results of a cohort study suggested short-term protection consistent with the hypothesis of trained immunity. One RCT, four cohort studies and one test-negative case-control suggested increased NIRD risk in recipients of inactivated influenza vaccines (IIV), whereas five test-negative case-control studies did not show an increased risk associated with a specific viral pathogen. Cross-protection against COVID-19 was suggested in one cross-sectional study on IIV but major biases could not be excluded. Results of four recent ecological studies on COVID-19 were challenging to interpret. Conclusions: Available data on LAIV are reassuring but not all those on IIV. A drastic reorientation of 2020-2021 influenza campaigns is probably not warranted but studies aiming to test COVID-19 risk modification among recipients of seasonal influenza vaccines should be planned and funded.

    Search related documents:
    Co phrase search for related documents
    • active surveillance and acute respiratory illness case: 1, 2, 3, 4, 5
    • active surveillance and acute respiratory infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • active surveillance and adenovirus mpv: 1
    • active surveillance and low likelihood: 1
    • acute respiratory illness and adaptive immune response: 1
    • acute respiratory illness and adaptive immunity: 1, 2, 3, 4
    • acute respiratory illness and adjusted ve: 1, 2
    • acute respiratory infection and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute respiratory infection and adaptive immune response innate: 1, 2, 3, 4, 5, 6
    • acute respiratory infection and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute respiratory infection and adenovirus mpv: 1, 2
    • acute respiratory infection and low likelihood: 1